0001004878-20-000029.txt : 20200221
0001004878-20-000029.hdr.sgml : 20200221
20200221165006
ACCESSION NUMBER: 0001004878-20-000029
CONFORMED SUBMISSION TYPE: AW
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20200221
DATE AS OF CHANGE: 20200221
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: AW
SEC ACT:
SEC FILE NUMBER: 333-233379
FILM NUMBER: 20640785
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
AW
1
withdrawpos233379feb-20.txt
LETTER WITHDRAW POS 229295
CEL-SCI CORPORATION
8229 Boone Blvd. #802
Vienna, VA 22182
(703) 506-9460
February 21, 2020
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: Post-Effective Amendment No. 1 to Registration Statement on Form S-1
File No. 333-233379
CEL-SCI Corporation (the "Company") requests that the above-captioned
Post-Effective Amendment No. 1 to registration statement 333-233379 be
withdrawn. The reason for this request is that the Post-Effective Amendment was
filed in error.
No securities were sold by means of the Post-Effective Amendment No. 1 to
the registration statement.
Very Truly Yours,
CEL-SCI CORPORATION
/s/ Geert R. Kersten
-----------------------------------
Geert R. Kersten
Chief Executive Officer
WTH:tg